Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing

This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amy Eichner, Laura A. Lewis, Bridget Leonard, Ryan M. Van Wagoner, Daniel Eichner, Matthew N. Fedoruk
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4eef0f70092f49fe8daacc537daa353a
record_format dspace
spelling oai:doaj.org-article:4eef0f70092f49fe8daacc537daa353a2021-11-17T07:05:24ZGeneric Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing2624-936710.3389/fspor.2021.692244https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fspor.2021.692244/fullhttps://doaj.org/toc/2624-9367This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases.Amy EichnerLaura A. LewisBridget LeonardRyan M. Van WagonerDaniel EichnerMatthew N. FedorukFrontiers Media S.A.articleprescription medicationanti-dopingrule violationminimum reporting leveladverse analytical findingSportsGV557-1198.995ENFrontiers in Sports and Active Living, Vol 3 (2021)
institution DOAJ
collection DOAJ
language EN
topic prescription medication
anti-doping
rule violation
minimum reporting level
adverse analytical finding
Sports
GV557-1198.995
spellingShingle prescription medication
anti-doping
rule violation
minimum reporting level
adverse analytical finding
Sports
GV557-1198.995
Amy Eichner
Laura A. Lewis
Bridget Leonard
Ryan M. Van Wagoner
Daniel Eichner
Matthew N. Fedoruk
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
description This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases.
format article
author Amy Eichner
Laura A. Lewis
Bridget Leonard
Ryan M. Van Wagoner
Daniel Eichner
Matthew N. Fedoruk
author_facet Amy Eichner
Laura A. Lewis
Bridget Leonard
Ryan M. Van Wagoner
Daniel Eichner
Matthew N. Fedoruk
author_sort Amy Eichner
title Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_short Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_full Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_fullStr Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_full_unstemmed Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
title_sort generic pharmaceuticals as a source of diuretic contamination in athletes subject to sport drug testing
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a
work_keys_str_mv AT amyeichner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT lauraalewis genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT bridgetleonard genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT ryanmvanwagoner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT danieleichner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
AT matthewnfedoruk genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting
_version_ 1718425857360396288